Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer-Reference-Cited by-同舟云学术

Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer

Published:2009-01 Issue:1 Volume:20 Page:34-40
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Jenkins P.,Freeman S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/1/34/308836/mdn560.pdf

Reference20 articles.

1. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up;Bonadonna;N Engl J Med,1995

2. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B;Budman;J Natl Cancer Inst,1998

3. Benefit of high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial;Group FAS;J Clin Oncol,2001

4. Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer;Chang;Eur J Cancer,2000

5. Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of care;Link;Cancer,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study on the analysis of influencing factors of neutropenia in endometrial cancer with adjuvant chemoradiotherapy;Radiation Oncology;2024-06-18

2. The Prognostic Utility of Lymphocyte-Based Measures and Ratios in Chemotherapy-Induced Febrile Neutropenia Patients following Granulocyte Colony-Stimulating Factor Therapy;Medicina;2022-10-24

3. Search for nutritional and inflammatory marker ratios to predict neutropenia in FEC therapy for breast cancer: A retrospective observational study;Int. Journal of Clinical Pharmacology and Therapeutics;2022-10-01

4. Post-Chemotherapy Monocytopenia as a Predictor of Chemotherapy – Induced Neutropenia in Breast Cancer Patients;Bali Medical Journal;2022-09-28

5. Real-world evaluation of supportive care using an electronic health record text-mining tool: G-CSF use in breast cancer patients;Supportive Care in Cancer;2022-08-31